Garheng Kong

Garheng has significant experience in the healthcare and biopharma sectors and has extensive investment, clinical and technical experience having served in both executive and non-executive roles helping to create and build high-growth and innovation-based healthcare businesses.

Garheng was previously managing general partner of Sofinnova Investments, Inc and general partner at Intersouth Partners. He served as a non-executive director of Venus Concept, Inc, Alimera Sciences and Avedro, Inc and as chair of Histogenics Corporation. Garheng’s early career included positions at GlaxoSmithKline, McKinsey and TherOx before he started his investing career.